HIV-1 protease inhibitors, phenylacetamide derivatives, enzymatic inhibitory activity, antiviral activity, darunavir-resistant HIV-1 variant
COVID-19, RdRp inhibitor, Non-nucleoside inhibitor, 2, 2'-((1H-indole-2, 3-diyl) bis (thio)) diacetamide derivatives
N, N'-diarylurea, Antibacterial, Structure-activity relationship, MRSA